Lifestyle & Healthslider Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations by Karine Ayoub April 26, 2022 by Karine Ayoub April 26, 2022 Pre-exposure prophylaxis (prevention) trial reduced risk of symptomatic COVID-19, with no severe disease or… 0 FacebookTwitterPinterestEmail